Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary

  Ovarian Neoplasms

  Free Subscription


Articles published in Am J Clin Pathol

Retrieve available abstracts of 6 articles:
HTML format
Text format



Single Articles


    March 2018
  1. NISHIKIMI K, Nakagawa K, Tate S, Matsuoka A, et al
    Uncommon Human Telomerase Reverse Transcriptase Promoter Mutations Are Associated With Poor Survival in Ovarian Clear Cell Carcinoma.
    Am J Clin Pathol. 2018;149:352-361.
    PubMed     Text format     Abstract available


    May 2017
  2. LI Z, Roth R, Rock JB, Lehman A, et al
    Dual Immunostain With SATB2 and CK20 Differentiates Appendiceal Mucinous Neoplasms From Ovarian Mucinous Neoplasms.
    Am J Clin Pathol. 2017;147:484-491.
    PubMed     Text format     Abstract available


    March 2017
  3. KHALIFA MA, Salama S, Vogel RI, Klein ME, et al
    Assessment of the Intraoperative Consultation Service Rendered by General Pathologists in a Scenario Where a Well-Defined Decision Algorithm Is Followed.
    Am J Clin Pathol. 2017;147:322-326.
    PubMed     Text format     Abstract available


    April 2016
  4. OCQUE R, Austin RM
    Follow-up of Women With Negative Pap Test Results and Abnormal Clinical Signs or Symptoms.
    Am J Clin Pathol. 2016;145:560-7.
    PubMed     Text format     Abstract available


  5. BUSCA A, Djordjevic B, Giassi A, Parra-Herran C, et al
    IFITM1 Is Superior to CD10 as a Marker of Endometrial Stroma in the Evaluation of Myometrial Invasion by Endometrioid Adenocarcinoma.
    Am J Clin Pathol. 2016;145:486-96.
    PubMed     Text format     Abstract available


    March 2016
  6. SERDY K, Yildiz-Aktas I, Li Z, Zhao C, et al
    The Value of Papanicolaou Tests in the Diagnosis of Endometrial Carcinoma: A Large Study Cohort From an Academic Medical Center.
    Am J Clin Pathol. 2016;145:350-4.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: